Anthropic revealed plans to list on the Nasdaq under the ticker ANT, filing paperwork Monday that both talks up artificial intelligence as one of the most consequential technologies in human history and warns, in striking detail, that it could pose catastrophic or even existential risks if mishandled.
The Claude chatbot developer reported $16.3 billion in revenue for the first half of the year, against losses of more than $80.7 billion, figures that underline both the scale of AI spending and how far the leading labs remain from profitability even as their valuations soar. Anthropic has not yet disclosed the number of shares it plans to sell, a price range, or a target date for the listing, but it will be the first fully AI-focused company to go public, making its debut a closely watched test case for investor appetite toward the sector.
Ninety pages of warnings
In its filing, Anthropic said concerns had been raised by policymakers, regulators, outside researchers and people within its own organisation that AI systems posed a significant risk to humanity. The company wrote that advanced AI "could, if not developed, deployed, and operated with appropriate safeguards, oversight, and security measures, pose catastrophic or existential risks to humanity, particularly if such systems were misused, replicated, weaponised, or allowed to operate with a high degree of autonomy." Roughly 90 of the document's pages are devoted to risk factors, more than double the space given to describing the business itself.
Anthropic also disclosed that its success depends heavily on a concentrated set of outside dependencies: a handful of cloud computing providers, Taiwanese chipmakers already straining to meet demand, and data centres clustered inside the United States. It separately warned of "regulatory action arising from harms associated with our AI models," language that echoes a wave of recent incidents in which AI agents from Anthropic and its rivals have been linked to cybersecurity and other technological breaches.
Betting big while warning loudly
Despite the caveats, the filing doubles as a sales pitch. Anthropic said it would often make forward investments "that may seem irresponsibly large at first glance," adding: "In general, we will aim to be bold but sane, and to win trust with a track record of successful bets." The company predicted AI would eventually unlock "millions of virtual agents with the ability to revolutionise every area of human endeavour," and could "profoundly accelerate the rate of progress in biology and medicine," potentially aiding the search for treatments for cancer and Alzheimer's.
Matt Orton, chief market strategist at Raymond James Investment, said the rapid growth and rapid losses disclosed in the filing would not come as a surprise to investors who have watched the sector closely, but that the detail would help the market understand where Anthropic's revenue is actually coming from. Peter Andersen, founder of Andersen Capital Management, called the planned listing "a significant milestone in the development of artificial intelligence," predicting its reception on Wall Street would prove "fairly indicative of the sentiment" toward continued AI investment more broadly.
Anthropic's chief rival, OpenAI, is reportedly preparing its own listing for early next year, meaning Monday's filing effectively opens a contest between the two best-funded AI labs for who can convince public markets that years of outsized losses are a feature, not a flaw, of building the technology both insist carries real risks to the people buying into it.
